U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07892755) titled 'Liquid Biopsy-Based Early Screening for Endometrial Cancer in Regional Chinese Populations' on Oct. 18.
Brief Summary: Endometrial cancer is one of the most common gynecological malignancies, and its incidence is rising. Currently, there is a lack of highly effective and non-invasive screening methods. Liquid biopsy, which analyzes cell-free DNA (cfDNA) in the blood, has emerged as a promising approach for early cancer detection. This observational study aims to develop and evaluate a non-invasive blood test to screen for early-stage endometrial cancer and to distinguish between benign and malignant endometrial lesions.
This study ...